Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Propylene glycol-induced side effects during intravenous nitroglycerin therapy

Abstract

Propylene glycol, an alcohol frequently used as a solvent in medical preparations, is considered non-toxic. We found that this solvent, used in a commercially available IV nitroglycerin solution, may cause hyperosmolality, hemolysis and lactic acidosis. The influence of kidney function as the main determinant in causing accumulation of this solvent and consequently hyperosmolality is emphasized. A review of the literature dealing with propylene glycol is given. The possible mechanisms of neurological disturbances occurring during IV nitroglycerin therapy are discussed.

This is a preview of subscription content, log in to check access.

References

  1. 1.

    Wade A, Reynolds JEF (eds) (1977) Martindale the extra pharmacopoeia. Pharmaceutical Press, London, p 629

  2. 2.

    Shook TL, Kirshenbaum JM, Hundley R, Shorey JM, Lamas GA (1984) Ethanol intoxication complicating intravenous nitroglycerin therapy. Ann Intern Med 101:498

  3. 3.

    Korn SH, Comer JB (1985) Intravenous nitroglycerin and ethanol intoxication. Ann Intern Med 102:274

  4. 4.

    Daly TJ, Camann WR, Dawley D, O'Rourke ME (1984) “Cocktail”-coronary care. N Engl J Med 310:1123

  5. 5.

    Bismuth C (1983) Management of specific poisonings. In: Tinker J, Rapin M (eds) Care of the critically ill patient. Springer, Berlin Heidelberg New York, p 829

  6. 6.

    Klaassen CD (1980) Propylene glycol. In: Goodman LS, Gilman A (eds) Goodman and Gilman's the pharmacological basis of therapeutics. MacMillan, New York, p 1647

  7. 7.

    Kaplan K, Reed MT, Davison R (1985) Intravenous nitroglycerin in unstable angina. Cardiovasc Rev Reports 6:279

  8. 8.

    Bekeris I, Baker C, Fenton J, Kimball D, Bermes E (1979) Propylene glycol as a cause of an elevated serum osmolality. Am J Clin Pathol 72:633

  9. 9.

    Kulick MI, Lewis NS, Bansal V, Warpeha R (1980) Hyperosmolality in the burn patient: analysis of an osmolal discrepancy. J Trauma 20:223

  10. 10.

    Fligner CL, Jack R, Twiggs GA, Ralays VA (1985) Hyperosmolality induced by propylene glycol. JAMA 253:1606

  11. 11.

    Glasgow AM, Boeckx RL, Miller MK, McDonald MG, August GP (1983) Hyperosmolality in small infants due to propylene glycol. Pediatrics 72:353

  12. 12.

    Morizono T, Johnstone BM (1975) Ototoxicity of chloramphenicol ear drops with propylene glycol as solvent. Med J Aust 2:634

  13. 13.

    Andersen KE, Storrs FJ (1982) Skin irritation caused by propylene glycol. Hautarzt 33:12

  14. 14.

    Cate JC, Hedrick R (1980) Propylene glycol intoxication and lactic acidosis. N Engl J Med 303:1237

  15. 15.

    Kelner MJ, Bailey DN (1985) Propylene glycol as a cause of lactic acidosis. J Anal Toxicol 9:40

  16. 16.

    Martin G, Finberg L (1970) Propylene glycol: a potentially toxic vehicle in liquid dosage form. J Pediatr 77:877

  17. 17.

    Arulanantham K, Genel M (1978) Central nervous system toxicity associated with ingestion of propylene glycol. J Pediatr 93:515

  18. 18.

    Demey H, Daelemans R, De Broe ME, Bossaert L (1984) Propylene glycol intoxication due to intravenous nitroglycerin. Lancet 1:1360

  19. 19.

    Dorwart WV, Chalmers L (1975) Comparison of methods for calculating serum osmolality from chemical concentrations, and the prognostic values of such calculations. Clin Chem 21:190

  20. 20.

    Weisberg HF (1975) Osmolality-calculated, “delta”, and more formulas. Clin Chem 21:1182

  21. 21.

    Glasser L, Sternglanz PD, Combie J, Robinson A (1973) Serum osmolality and its applicability to drug overdose. Am J Clin Pathol 60:695

  22. 22.

    Gennari FJ (1984) Serum osmolality. Uses and limitations. N Engl J Med 310:102

  23. 23.

    Yu DK, Sawchuk RJ (1983) Gas-liquid chromatographic determination of propylene glycol in plasma and urine. Clin Chem 29:2088

  24. 24.

    Yu DK, Elmquist WF and Sawchuk RJ (1985) Pharmacokinetics of propylene glycol in humans during multiple dosage regimens. J Pharm Sci 74:876

  25. 25.

    Ruddick JA (1972) Toxicology, metabolism and biochemistry of 1,2 propanediol. Toxicol Appl Pharmacol 21:102

  26. 26.

    Brittain RT, D'Arcy PF (1962) Hematologic effects following the intravenous injection of propylene glycol in the rabbit. Toxicol Appl Pharmacol 4:738

  27. 27.

    Cadwallader DE (1963) Behaviour of erythrocytes in various solvent systems. J Pharm Sci 52:1175

  28. 28.

    Potter BJ (1958) Haemoglobinuria caused by propylene glycol. Br J Pharmacol 13:385

  29. 29.

    Randolph TG, Mallery OT (1944) The effect of propylene glycol on erythrocytes. J Lab Clin Med 29:197

  30. 30.

    Varriale P, Kwa R, Vyas P (1984) Intravenous nitroglycerin in transfusion therapy for severe anemia. Arch Intern Med 144:401

  31. 31.

    Col J, Col-Debeys C, Lavenne-Pardonge E, Meert PH, Hericks L, Broze MC, Moriau M (1985) Propylene glycol-induced heparin resistance during nitroglycerin infusion. Am Heart J 110:171

  32. 32.

    Telford AM, Wilson C (1981) Trial of heparin versus atenolol in prevention of myocardial infarction in intermediate coronary syndrome. Lancet 1:1225

  33. 33.

    Wood P (1961) Acute and subacute coronary insufficiency. Br Med J 1:1779

  34. 34.

    Shorey J, Bhardwaj N, Loscalzo J (1984) Acute Wernicke's encephalopathy after intravenous infusion of high-dose nitroglycerin. Ann Intern Med 101:500

  35. 35.

    Ohar JM, Fowler AA, Selhorst JB, Glauser FL (1985) Intravenous nitroglycerin administration and ethanol. Ann Intern Med 102:558

  36. 36.

    Alexander J, Kaplan K, Davison R, Blonsky ER, Gilbert J (1983) Intravenous nitroglycerin-induced abducens nerve palsy. Am Heart J 106:1159

  37. 37.

    Gagnon RL, Marsh ML, Smith RW, Shapiro HM (1979) Intracranial hypertension caused by nitroglycerin. Anesthesiology 51:86

  38. 38.

    Cottrell JE, Gupta B, Rappaport H, Turndorf H, Ransohoff J, Flamm ES (1980) Intracranial pressure during nitroglycerin-induced hypotension. J Neurosurg 53:309

  39. 39.

    Ghani GA, Sung YF, Weinstein MS, Tindall GT, Fleischer AS (1983) Effects of intravenous nitroglycerin on the intracranial pressure and volume-pressure response. J Neurosurg 58:562

  40. 40.

    Ohar JM, Fowler AA, Selhorst JB, Glauser FL (1985) Intravenous nitroglycerin-induced intracranial hypertension. Crit Care Med 13:867

Download references

Author information

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Demey, H.E., Daelemans, R.A., Verpooten, G.A. et al. Propylene glycol-induced side effects during intravenous nitroglycerin therapy. Intensive Care Med 14, 221–226 (1988). https://doi.org/10.1007/BF00717993

Download citation

Key words

  • Nitroglycerin
  • Propylene glycol
  • Hyperosmolality
  • Coma
  • Lactic acidosis
  • Hemolysis
  • Renal failure